As of 4:00pm ET
| -0.03 / -2.29%|
The 1 analysts offering 12-month price forecasts for Endocyte Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +56.25% increase from the last price of 1.28.
The current consensus among 2 polled investment analysts is to Hold stock in Endocyte Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.